<DOC>
	<DOC>NCT02456532</DOC>
	<brief_summary>This proposal will assess risks for transition from therapeutic hypnotic use to abuse in people with insomnia. The investigators will study a hypothesized at-risk sub-population, insomniacs with hyperarousal, and compare two hypnotics, a drug with mood effects, eszopiclone, versus one without mood effects, zolpidem.</brief_summary>
	<brief_title>Safety and Efficacy of Chronic Hypnotic Use 2</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<mesh_term>Hypnotics and Sedatives</mesh_term>
	<criteria>DSM5 diagnosis of insomnia acute or unstable medical disease, current or past history of psychiatric disease, alcoholism or drug abuse, and other primary sleep disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>